Literature DB >> 3907364

Immunohistochemical evidence for the expression of the carcinoembryonic antigen by human thymic epithelial cells in vitro and in neoplastic conditions.

W Savino, D Durand, M Dardenne.   

Abstract

Thymic epithelial cells (TECs), which are known to influence T-cell differentiation, may undergo phenotypic changes and lose some differentiation antigens (for example, the HLA-DR complex) in neoplastic conditions and when they are grown in culture. Using an indirect immunofluorescence assay, the authors investigated the expression of the carcinoembryonic antigen (CEA) by normal cultured or pathologic human TECs. This antigen, which can be regarded as a marker of undifferentiation, disappears during the normal development of epithelial tissues and reappears in neoplastic conditions. In normal as well as hyperplastic (myasthenia gravis-associated) thymuses, the epithelial network (revealed in double-labeling experiments by an anti-keratin monoclonal antibody) is virtually CEA-negative, except for the specific labeling observed on some cells of Hassall's corpuscles. In thymomatous epithelial cells, however, a strong and specific fluorescent labeling was consistently detected in all thymomas studied. Thymic epithelial cells grown in cultures from fragments of normal thymuses also expressed CEA on their cell membranes. Interestingly, the relative number of CEA-positive cells increased as a function of the age of the primary culture and reached virtually 100% when monolayers became confluent (Days 12-14). Moreover, using an ELISA assay, the authors demonstrated the presence of CEA in supernatants from TEC cultures. Interestingly, the amount of CEA in these supernatants decreased as a function of the age of the culture. In addition, a marked inhibition of TEC proliferation was observed after treating the cultures with an anti-CEA serum. Our results demonstrate that CEA is expressed not only in situ by differentiated neoplastic TECs but also by normal TECs cultured in vitro. In addition, the inhibitory action of the anti-CEA serum on TEC proliferation suggests that CEA may act physiologically as a growth factor for proliferating epithelial cells. In this respect, cultures of human TECs represent a good model for further studies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907364      PMCID: PMC1887930     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  The ultrastructure of the normal human thymus: a study of 36 cases.

Authors:  R M Bearman; G D Levine; K G Bensch
Journal:  Anat Rec       Date:  1978-03

2.  Ultrastructure of the rat thymus. A transmission, scanning electron microscope, and morphometric study.

Authors:  W S Hwang; T Y Ho; S C Luk; G T Simon
Journal:  Lab Invest       Date:  1974-11       Impact factor: 5.662

3.  Letter: In-vitro production of carcinoembryonic antigen by normal and neoplastic colon.

Authors:  J Breborowitz; G C Easty; A M Neville
Journal:  Lancet       Date:  1973-12-15       Impact factor: 79.321

4.  Light and electron microscopic study of the normal and pathological thymus of the rat. I. The normal thymus.

Authors:  U van Haelst
Journal:  Z Zellforsch Mikrosk Anat       Date:  1967

5.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

6.  Demonstration of carcinoembryonic antigen in human breast carcinomas by the immunoperoxidase technique.

Authors:  R A Walker
Journal:  J Clin Pathol       Date:  1980-04       Impact factor: 3.411

7.  CEA and NCA in benign and malignant breast tumors.

Authors:  M Nap; H Keuning; P Burtin; J W Oosterhuis; G Fleuren
Journal:  Am J Clin Pathol       Date:  1984-11       Impact factor: 2.493

8.  Factors affecting the expression of carcinoembryonic antigen at the surface of cultured human colon carcinoma cells.

Authors:  K L Rosenthal; W A Tompkins; W E Rawls
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

Review 9.  Carcinoembryonic antigen (CEA) in clinical medicine: historical perspectives, pitfalls and projections.

Authors:  P Gold; J Shuster; S O Freedman
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

10.  Location of T cell and major histocompatibility complex antigens in the human thymus.

Authors:  A K Bhan; E L Reinherz; S Poppema; R T McCluskey; S F Schlossman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  6 in total

1.  Immunohistochemical studies on a human thymic epithelial cell subset defined by the anti-cytokeratin 18 monoclonal antibody.

Authors:  W Savino; M Dardenne
Journal:  Cell Tissue Res       Date:  1988-10       Impact factor: 5.249

2.  Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.

Authors:  V B Kraus; E A Harden; B Wittels; J O Moore; B F Haynes
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

3.  Thymomatous epithelial cells and skeletal muscle share a common epitope defined by a monoclonal antibody.

Authors:  M Dardenne; W Savino; J F Bach
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

4.  Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.

Authors:  David Escors
Journal:  New J Sci       Date:  2014-01-05

5.  Clinical and immunohistochemical study of eight cases with thymic carcinoma.

Authors:  Masaki Tomita; Yasunori Matsuzaki; Masao Edagawa; Masayuki Maeda; Tetsuya Shimizu; Masaki Hara; Toshio Onitsuka
Journal:  BMC Surg       Date:  2002-05-23       Impact factor: 2.102

6.  Prognostic Value of Preoperative Serum Carcinoembryonic Antigen for Overall Survival and Recurrence-Free Survival in Resectable Thymic Epithelial Tumors.

Authors:  Yang-Yu Huang; Xuan Liu; Shen-Hua Liang; Yu Hu; Guo-Wei Ma
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.